Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results
Provided By Globe Newswire
Last update: Oct 14, 2022
OLDSMAR, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2022.
